Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1
Histone H2A lysine 119 (H2AK119Ub) is monoubiquitinated by Polycomb repressive complex 1 and deubiquitinated by Polycomb repressive deubiquitinase complex (PR-DUB). PR-DUB cleaves H2AK119Ub to restrict focal H2AK119Ub at Polycomb target sites and to protect active genes from aberrant silencing. The PR-DUB subunits (BAP1 and ASXL1) are among the most frequently mutated epigenetic factors in human cancers. How PR-DUB establishes specificity for H2AK119Ub over other nucleosomal ubiquitination sites and how disease-associated mutations of the enzyme affect activity are unclear. Here, we determine a cryo-EM structure of human BAP1 and the ASXL1 DEUBAD in complex with a H2AK119Ub nucleosome. Our structural, biochemical, and cellular data reveal the molecular interactions of BAP1 and ASXL1 with histones and DNA that are critical for restructuring the nucleosome and thus establishing specificity for H2AK119Ub. These results further provide a molecular explanation for how >50 mutations in BAP1 and ASXL1 found in cancer can dysregulate H2AK119Ub deubiquitination, providing insight into understanding cancer etiology.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Science advances - 9(2023), 32 vom: 09. Aug., Seite eadg9832 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Thomas, Jonathan F [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 11.08.2023 Date Revised 21.09.2023 published: Print-Electronic UpdateOf: bioRxiv. 2023 Feb 23;:. - PMID 36865140 Citation Status MEDLINE |
---|
doi: |
10.1126/sciadv.adg9832 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360561411 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360561411 | ||
003 | DE-627 | ||
005 | 20231226083255.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1126/sciadv.adg9832 |2 doi | |
028 | 5 | 2 | |a pubmed24n1201.xml |
035 | |a (DE-627)NLM360561411 | ||
035 | |a (NLM)37556531 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Thomas, Jonathan F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.08.2023 | ||
500 | |a Date Revised 21.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a UpdateOf: bioRxiv. 2023 Feb 23;:. - PMID 36865140 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Histone H2A lysine 119 (H2AK119Ub) is monoubiquitinated by Polycomb repressive complex 1 and deubiquitinated by Polycomb repressive deubiquitinase complex (PR-DUB). PR-DUB cleaves H2AK119Ub to restrict focal H2AK119Ub at Polycomb target sites and to protect active genes from aberrant silencing. The PR-DUB subunits (BAP1 and ASXL1) are among the most frequently mutated epigenetic factors in human cancers. How PR-DUB establishes specificity for H2AK119Ub over other nucleosomal ubiquitination sites and how disease-associated mutations of the enzyme affect activity are unclear. Here, we determine a cryo-EM structure of human BAP1 and the ASXL1 DEUBAD in complex with a H2AK119Ub nucleosome. Our structural, biochemical, and cellular data reveal the molecular interactions of BAP1 and ASXL1 with histones and DNA that are critical for restructuring the nucleosome and thus establishing specificity for H2AK119Ub. These results further provide a molecular explanation for how >50 mutations in BAP1 and ASXL1 found in cancer can dysregulate H2AK119Ub deubiquitination, providing insight into understanding cancer etiology | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Histones |2 NLM | |
650 | 7 | |a Nucleosomes |2 NLM | |
650 | 7 | |a Lysine |2 NLM | |
650 | 7 | |a K3Z4F929H6 |2 NLM | |
650 | 7 | |a Ubiquitin Thiolesterase |2 NLM | |
650 | 7 | |a EC 3.4.19.12 |2 NLM | |
650 | 7 | |a Polycomb-Group Proteins |2 NLM | |
650 | 7 | |a Drosophila Proteins |2 NLM | |
650 | 7 | |a ASXL1 protein, human |2 NLM | |
650 | 7 | |a Repressor Proteins |2 NLM | |
650 | 7 | |a BAP1 protein, human |2 NLM | |
650 | 7 | |a Tumor Suppressor Proteins |2 NLM | |
700 | 1 | |a Valencia-Sánchez, Marco Igor |e verfasserin |4 aut | |
700 | 1 | |a Tamburri, Simone |e verfasserin |4 aut | |
700 | 1 | |a Gloor, Susan L |e verfasserin |4 aut | |
700 | 1 | |a Rustichelli, Samantha |e verfasserin |4 aut | |
700 | 1 | |a Godínez-López, Victoria |e verfasserin |4 aut | |
700 | 1 | |a De Ioannes, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Lee, Rachel |e verfasserin |4 aut | |
700 | 1 | |a Abini-Agbomson, Stephen |e verfasserin |4 aut | |
700 | 1 | |a Gretarsson, Kristjan |e verfasserin |4 aut | |
700 | 1 | |a Burg, Jonathan M |e verfasserin |4 aut | |
700 | 1 | |a Hickman, Allison R |e verfasserin |4 aut | |
700 | 1 | |a Sun, Lu |e verfasserin |4 aut | |
700 | 1 | |a Gopinath, Saarang |e verfasserin |4 aut | |
700 | 1 | |a Taylor, Hailey F |e verfasserin |4 aut | |
700 | 1 | |a Sun, Zu-Wen |e verfasserin |4 aut | |
700 | 1 | |a Ezell, Ryan J |e verfasserin |4 aut | |
700 | 1 | |a Vaidya, Anup |e verfasserin |4 aut | |
700 | 1 | |a Meiners, Matthew J |e verfasserin |4 aut | |
700 | 1 | |a Cheek, Marcus A |e verfasserin |4 aut | |
700 | 1 | |a Rice, William J |e verfasserin |4 aut | |
700 | 1 | |a Svetlov, Vladimir |e verfasserin |4 aut | |
700 | 1 | |a Nudler, Evgeny |e verfasserin |4 aut | |
700 | 1 | |a Lu, Chao |e verfasserin |4 aut | |
700 | 1 | |a Keogh, Michael-Christopher |e verfasserin |4 aut | |
700 | 1 | |a Pasini, Diego |e verfasserin |4 aut | |
700 | 1 | |a Armache, Karim-Jean |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Science advances |d 2015 |g 9(2023), 32 vom: 09. Aug., Seite eadg9832 |w (DE-627)NLM247717614 |x 2375-2548 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2023 |g number:32 |g day:09 |g month:08 |g pages:eadg9832 |
856 | 4 | 0 | |u http://dx.doi.org/10.1126/sciadv.adg9832 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2023 |e 32 |b 09 |c 08 |h eadg9832 |